THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES

Header Logo

Connection

Udho Thadani to Administration, Oral

This is a "connection" page, showing publications Udho Thadani has written about Administration, Oral.
Connection Strength

0.161
  1. Oral nitrates: more than symptomatic therapy in coronary artery disease? Cardiovasc Drugs Ther. 1997 May; 11 Suppl 1:213-8.
    View in: PubMed
    Score: 0.034
  2. Nitrates for unstable angina. Cardiovasc Drugs Ther. 1994 Oct; 8(5):719-26.
    View in: PubMed
    Score: 0.029
  3. Short and long-acting oral nitrates for stable angina pectoris. Cardiovasc Drugs Ther. 1994 Aug; 8(4):611-23.
    View in: PubMed
    Score: 0.029
  4. Isosorbide-5-mononitrate in angina pectoris: plasma concentrations and duration of effects after acute therapy. Clin Pharmacol Ther. 1987 Jul; 42(1):58-65.
    View in: PubMed
    Score: 0.017
  5. Beta adrenergic blocking agents for exertional angina pectoris. Herz. 1982 Jun; 7(3):179-87.
    View in: PubMed
    Score: 0.012
  6. Oral isosorbide dinitrate in angina pectoris: comparison of duration of action an dose-response relation during acute and sustained therapy. Am J Cardiol. 1982 Feb 01; 49(2):411-9.
    View in: PubMed
    Score: 0.012
  7. Oral isosorbide dinitrate in the treatment of angina pectoris. Dose-response relationship and duration of action during acute therapy. Circulation. 1980 Sep; 62(3):491-502.
    View in: PubMed
    Score: 0.011
  8. Propranolol in angina pectoris: duration of improved exercise tolerance and circulatory effects after acute oral administration. Am J Cardiol. 1979 Jul; 44(1):118-25.
    View in: PubMed
    Score: 0.010
  9. Comparison of adrenergic beta-receptor antagonists in angina pectoris. Br Med J. 1973 Jan 20; 1(5846):138-42.
    View in: PubMed
    Score: 0.006
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.

THIS IS A DEVELOPMENT VERSION OF PROFILES. PLEASE GO TO THE PRODUCTION ENVIRONMENT FOR UPDATES